Physician profile
Ryan Griggs
NPI 1811347040
$12,730.00
in general payments reported to CMS, 2019-2025
42 companies · $1,114 in 2025
The $1,114 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2021: $2,368 · 2022: $4,652 · 2023: $2,960 · 2024: $1,407 · 2025: $1,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,323 · Travel and Lodging: $982 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,323.23 |
| Travel and Lodging | $981.95 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $5,010.78 | 2021-2025 | Titan, Coloplast Tfl Drive, Genesis |
| Boston Scientific Corporation | $3,847.38 | 2019-2023 | Ams 700 Cxr Rte Kit, Lithovue |
| Innovation Technologies INC | $640.81 | 2021-2024 | Irrisept |
| Astellas Pharma US INC | $446.70 | 2022-2024 | Xtandi, Myrbetriq |
| Axonics, INC. | $291.05 | 2023-2024 | Bulkamid, Axonics |
| Endo Pharmaceuticals INC. | $233.98 | 2021-2023 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $218.41 | 2022-2025 | Erleada, Akeega, Balversa |
| Pfizer INC. | $196.61 | 2021-2024 | |
| Abbvie INC. | $165.76 | 2021-2025 | |
| Antares Pharma, INC. | $134.31 | 2022-2023 | Xyosted, Tlando |
| Medtronic, INC. | $130.25 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.20 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $107.86 | 2025 | Keytruda |
| Procept Biorobotics Corporation | $104.50 | 2024 | Aquabeam System |
| Sumitomo Pharma America, INC. | $97.08 | 2023-2025 | Gemtesa, Orgovyx |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $69.77 | 2024 | Xiaflex, Aveed |
| Verity Pharmaceuticals INC. | $69.34 | 2024-2025 | Trelstar, Tlando |
| Astrazeneca Pharmaceuticals LP | $62.60 | 2022-2023 | Lynparza |
| C. R. Bard, INC. & Subsidiaries | $60.21 | 2023 | Bard Urinary Drainage Bag |
| Photocure INC | $56.45 | 2022 | |
| Medtronic USA, INC. | $56.20 | 2019 | |
| Progenics Pharmaceuticals, INC. | $56.00 | 2022 | |
| Myriad Genetic Laboratories, INC. | $50.76 | 2024-2025 | Myrisk |
| Tolmar, INC. | $48.45 | 2023-2024 | |
| Urovant Sciences INC | $47.24 | 2022 | |
| Valencia Technologies Corporation | $43.64 | 2025 | Ecoin Device Kit |
| Ferring Pharmaceuticals INC. | $39.61 | 2025 | Adstiladrin |
| Dentsply Ih Ab | $32.49 | 2024 | Lofric |
| Convatec INC. | $29.90 | 2024 | |
| Sun Pharmaceutical Industries INC. | $26.37 | 2022 | |
| Becton, Dickinson and Company | $26.27 | 2024 | Bard Urinary Drainage Bag |
| Accord Healthcare, INC. | $24.05 | 2022 | |
| Olympus America INC. | $23.82 | 2024 | Itind System |
| Myovant Sciences INC. | $22.52 | 2022 | |
| Agiliti Surgical, INC. | $21.71 | 2025 | Koelis Trinity Mri/US Fusion, Sonablate Hifu |
| Telix Pharmaceuticals | $20.91 | 2024 | Illuccix |
| Tolmar Pharmaceuticals, INC. | $20.54 | 2022 | |
| Amgen INC. | $18.84 | 2022 | |
| Dendreon Pharmaceuticals LLC | $17.69 | 2019 | |
| Viiv Healthcare Company | $17.58 | 2025 | Apretude |
| Blue Earth Diagnostics | $15.19 | 2022 | |
| Allergan, INC. | $14.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Griggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.